4.5 Article

Applicability of confocal laser scanning microscopy for evaluation and monitoring of cutaneous wound healing

Journal

JOURNAL OF BIOMEDICAL OPTICS
Volume 17, Issue 7, Pages -

Publisher

SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
DOI: 10.1117/1.JBO.17.7.076016

Keywords

in vivo reflectance confocal microscopy; noninvasive skin imaging; wound healing

Ask authors/readers for more resources

There is a high demand for noninvasive imaging techniques for wound assessment. In vivo reflectance confocal laser scanning microscopy (CLSM) represents an innovative optical technique for noninvasive evaluation of normal and diseased skin in vivo at near cellular resolution. This study was designed to test the feasibility of CLSM for noninvasive analysis of cutaneous wound healing in 15 patients (7 male/8 female), including acute and chronic, superficial and deep dermal skin wounds. A commercially available CLSM system was used for the assessment of wound bed and wound margins in order to obtain descriptive cellular and morphological parameters of cutaneous wound repair noninvasively and over time. CLSM was able to visualize features of cutaneous wound repair in epidermal and superficial dermal wounds, including aspects of inflammation, neovascularisation, and tissue remodelling in vivo. Limitations include the lack of mechanic fixation of the optical system on moist surfaces restricting the analysis of chronic skin wounds to the wound margins, as well as a limited optical resolution in areas of significant slough formation. By describing CLSM features of cutaneous inflammation, vascularisation, and epithelialisation, the findings of this study support the role of CLSM in modern wound research and management. (C) 2012 Society of Photo-Optical Instrumentation Engineers (SPIE). [DOI: 10.1117/1.JBO.17.7.076016]

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Allergy

Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE study

Mojca Bizjak, Mitja Kosnik, Dejan Dinevski, Simon Francis Thomsen, Daria Fomina, Elena Borzova, Kanokvalai Kulthanan, Raisa Meshkova, Dalia Melina Ahsan, Mona Al-Ahmad, Sabine Altrichter, Andrea Bauer, Maxi Brockstadt, Celia Costa, Semra Demir, Roberta Fachini Criado, Luis Felipe Ensina, Asli Gelincik, Ana Maria Gimenez-Arnau, Margarida Goncalo, Maia Gotua, Jesper Gronlund Holm, Naoko Inomata, Alicja Kasperska-Zajac, Maryam Khoshkhui, Aliya Klyucharova, Emek Kocatuerk, Rongbiao Lu, Michael Makris, Natalya Maltseva, Jovan Miljkovic, Maria Pasali, Marisa Paulino, David Pesque, Jonny Peter, German Dario Ramon, Carla Ritchie, Solange Oliveira Rodrigues Valle, Michael Rudenko, Agnieszka Sikora, Eduardo M. Souza Lima, Nicola Wagner, Paraskevi Xepapadaki, Xiaoyang Xue, Zuotao Zhao, Dorothea Terhorst-Molawi, Marcus Maurer

Summary: Cold urticaria (ColdU) can lead to wheals or angioedema in response to cold exposure, and may be associated with cold-induced anaphylaxis (ColdA). The research found that ColdA can be triggered by a variety of factors, including immersion in cold water and exposure to cold air. Patients with concomitant chronic spontaneous urticaria have a lower risk of ColdA in ColdU.

ALLERGY (2022)

Article Allergy

Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity

Margitta Worm, Aikaterina Alexiou, Andrea Bauer, Regina Treudler, Gerda Wurpts, Heinrich Dickel, Timo Buhl, Sabine Mueller, Andreas Jung, Randolf Brehler, Joachim Fluhr, Ludger Klimek, Norbert Muelleneisen, Wolfgang Pfuetzner, Ulrike Raap, Stefani Roeseler, Sandra Schuh, Hartmut Timmermann, Guido Heine, Bettina Wedi, Knut Brockow

Summary: In this study, the management and outcome of suspected SARS-CoV-2 vaccine hypersensitivity were assessed. It was found that proven IgE-mediated hypersensitivity to SARS-CoV-2 vaccines is extremely rare and not increased in comparison with reported hypersensitivity to other vaccines. The value of skin tests is unclear and nonspecific reactions should be considered.

ALLERGY (2022)

Article Dermatology

Acidic skin care promotes cutaneous microbiome recovery and skin physiology in an acute stratum corneum stress model

Joachim W. Fluhr, Peter Menzel, Rolf Schwarzer, Benjamin Kaestle, Michaela Arens-Corell, Lina Praefke, Nikolai K. Tsankov, Dessyslava G. Nikolaeva, Laurent Misery, Razvigor Darlenski

Summary: This study investigated the effects of different cosmetic lotions on skin microbiome and skin physiology after mild tape stripping. The results showed that the lotions accelerated the recovery of the microbiome and increased stratum corneum hydration. The composition of the lotion and induced repair mechanism may be responsible for the accelerated normalization of the microbiome.

SKIN PHARMACOLOGY AND PHYSIOLOGY (2022)

Article Biochemical Research Methods

Glycerol and natural sugar-derived complex modulate differentially stratum corneum water-binding properties and structural parameters in an in vitro Raman-desorption model

Joachim W. Fluhr, Ali Tfayli, Razvigor Darlenski, Maxim E. Darvin, Nicolas Joly-Tonetti, Nadege Lachmann

Summary: This study aimed to establish an in vitro SC model to evaluate differences in the efficacy of a natural sugar-derived complex in combination with glycerol and a botanical extract in modulating SC water binding and structural proteins and barrier lipids.

JOURNAL OF BIOPHOTONICS (2023)

Article Allergy

Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria

Dorothea Terhorst-Molawi, Tomasz Hawro, Eva Grekowitz, Lea Kiefer, Kunal Merchant, Diego Alvarado, Lawrence J. Thomas, Thomas Hawthorne, Elizabeth Crowley, Margo Heath-Chiozzi, Martin Metz, Marcus Maurer

Summary: In this study, Barzolvolimab showed good tolerability and demonstrated significant reduction in skin mast cells and circulating tryptase levels in patients with chronic inducible urticaria (CIndU). It also improved disease control and quality of life in clinical settings.

ALLERGY (2023)

Editorial Material Dermatology

S3 Guideline Urticaria. Part 1: Classification and diagnosis of urticaria - German-language adaptation of the international S3 Guideline

Torsten Zuberbier, Sabine Altrichter, Sabine Bauer, Randolf Brehler, Knut Brockow, Corinna Dressler, Joachim Fluhr, Matthew Gaskins, Eckard Hamelmann, Kathrin Kuehne, Hans Merk, Norbert K. Muelleneisen, Alexander Nast, Heidi Olze, Hagen Ott, Marc Pleimes, Franziska Rueff, Petra Staubach-Renz, Bettina Wedi, Marcus Maurer

Summary: This publication is the first section of the Urticaria guideline, which covers the classification and diagnosis of urticaria, as well as the causes, triggering factors, and pathomechanisms. It also addresses strategies for efficient diagnosis of different subtypes of urticaria, providing important guidance for individualized, patient-centered treatment.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2023)

Editorial Material Dermatology

S3 Guideline Urticaria. Part 1: Classification and diagnosis of urticaria - German-language adaptation of the international S3 Guideline

Torsten Zuberbier, Sabine Altrichter, Sabine Bauer, Randolf Brehler, Knut Brockow, Corinna Dressler, Joachim Fluhr, Matthew Gaskins, Eckard Hamelmann, Kathrin Kuehne, Hans Merk, Norbert K. Muelleneisen, Alexander Nast, Heidi Olze, Hagen Ott, Marc Pleimes, Franziska Rueff, Petra Staubach-Renz, Bettina Wedi, Marcus Maurer

Summary: This article is the first section of the Urticaria Guideline, focusing on the classification and diagnosis of urticaria, as well as strategies for efficient diagnosis. Urticaria is a severe allergic disease with a lifetime prevalence of almost 20%, which significantly impacts the quality of life and performance of those affected.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2023)

Article Dermatology

S3 Guideline Urticaria. Part 2: Treatment of urticaria - German-language adaptation of the international S3 guideline

Torsten Zuberbier, Sabine Altrichter, Sabine Bauer, Randolf Brehler, Knut Brockow, Corinna Dressler, Joachim Fluhr, Matthew Gaskins, Eckard Hamelmann, Kathrin Kuehne, Hans Merk, Norbert K. Muelleneisen, Alexander Nast, Heidi Olze, Hagen Ott, Marc Pleimes, Franziska Rueff, Petra Staubach-Renz, Bettina Wedi, Marcus Maurer

Summary: This publication is the second part of the German-language S3 guideline on urticaria, focusing on the management of the condition. It highlights the importance of symptomatic treatment when causal factors cannot be eliminated. The recommended first-line treatment is non-sedating H1 antihistamines.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2023)

Review Chemistry, Applied

How do the skin barrier and microbiome adapt to the extra-uterine environment after birth? Implications for the clinical practice

Razvigor Darlenski, Joachim W. Fluhr

Summary: The skin's multiple protective functions rely on the interactions between epithelial skin, immune cells, and the commensal microbiota. After birth, the skin barrier undergoes dynamic adaptation, with specific differences in structure and physiology compared to adult skin. These adaptations include thinner stratum corneum, increased protease activity, and accelerated proliferation in infant skin. The colonization of commensal bacteria immediately after birth plays a crucial role in the maturation of the immune system. This paper focuses on the ongoing adaptation of the human skin barrier after birth and the interactions between the skin barrier, microbiota, and immune system.

INTERNATIONAL JOURNAL OF COSMETIC SCIENCE (2023)

Review Dermatology

Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don't Know

Dorothea Terhorst-Molawi, Lena Fox, Frank Siebenhaar, Martin Metz, Marcus Maurer

Summary: The goal of treating chronic spontaneous urticaria is to effectively and safely eliminate the disease. Current treatment options target mast cell mediators or activators. Treatment should continue until complete control of the disease and normalization of quality of life.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2023)

Article Dermatology

In vivo transepidermal water loss: Validation of a new multi-sensor open chamber water evaporation system Tewameter TM Hex

Joachim W. Fluhr, Georg Wiora, Dessyslava G. Nikolaeva, Laurent Misery, Razvigor Darlenski

Summary: This study aimed to compare the new multi-sensor probe (Tewameter TM Hex) with the established Tewameter TM 300 probe and obtain reference data for transepidermal energy loss and water vapor concentration on the skin. The results showed a significant correlation between TM Hex and TM 300, with TM Hex providing more accurate measurements.

SKIN RESEARCH AND TECHNOLOGY (2023)

Review Allergy

Positive Basophil Tests Are Linked to High Disease Activity and Other Features of Autoimmune Chronic Spontaneous Urticaria: A Systematic Review

Sherezade Monino-Romero, Yana Hackler, Tiia-Linda Okas, Eva Maria Grekowitz, Joachim W. Fluhr, Vincent Hultsch, Lea Alice Kiefer, Polina Pyatilova, Dorothea Terhorst-Molawi, Yi-Kui Xiang, Frank Siebenhaar, Marcus Maurer, Pavel Kolkhir

Summary: Chronic spontaneous urticaria (CSU) is believed to have an autoimmune component in at least 8% of patients, characterized by mast cell-activating IgG autoantibodies. Basophil tests such as BAT and BHRA are considered the best single tests for diagnosing autoimmune CSU. However, the relationship between positive basophil tests and CSU characteristics, patient demographics, and treatment response remains poorly understood.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2023)

Article Allergy

A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics

Ulrike Foerster-Ruhrmann, Dafni Stergioudi, Agnieszka J. Szczepek, Joachim W. Fluhr, Torsten Zuberbier, Heidi Olze, Karl-Christian Bergmann

Summary: This retrospective study compared the clinical efficacy of mepolizumab, benralizumab, omalizumab, and dupilumab in patients with severe asthma and comorbid chronic rhinosinusitis with nasal polyps. The results showed that dupilumab had the most significant improvement in asthma and nasal symptoms. Overall, T2-targeting biologics effectively treated severe asthma with comorbid chronic rhinosinusitis with nasal polyps, but the efficacy varied among different biologics in treating chronic rhinosinusitis with nasal polyps.

WORLD ALLERGY ORGANIZATION JOURNAL (2023)

Article Allergy

Disease Impact, Diagnostic Delay, and Unmet Medical Needs of Patients With Cholinergic Urticaria in German-Speaking Countries

Sabine Altrichter, Emilia Mellerowicz, Dorothea Terhorst-Molawi, Eva Grekowitz, Karsten Weller, Marcus Maurer

Summary: Patients with CholU have many unmet medical needs, and there is a need for improvement in the diagnostic workup and patient care, as well as better treatment options.

FRONTIERS IN ALLERGY (2022)

No Data Available